<ѻýҕl>Significant Decline in Precancerous Cervical Lesions in U.S.ѻýҕl> Proportion of lesions with HPV16/18 fall across age, ethnic groups Feb 21, 2019
<ѻýҕl>'Encouraging' Early Data with Keytruda in High-Risk Bladder Caѻýҕl> Will responses in non-muscle-invasive, BCG-unresponsive disease prove durable? Feb 17, 2019
<ѻýҕl>Bladder Ca Treatment Enters 'Post-Checkpoint' Eraѻýҕl> Early trials show responses with antibody-drug conjugates Feb 16, 2019
<ѻýҕl>Rapid Heart Rate Tied to Higher Mortality in Cancer Patientsѻýҕl> Unexplained tachycardia linked with threefold increase in risk of death Jan 28, 2019
<ѻýҕl>Genetic Profiling Disappoints for CUP Survivalѻýҕl> But testing in cancer of unknown primary site did help with prognosis Jan 24, 2019
<ѻýҕl>High Response Rate in HER2+ Esophagogastric Cancerѻýҕl> Summary findings from the Gastrointestinal Cancers Symposium Jan 23, 2019
<ѻýҕl>Metastatic Gastric Ca Treatments Show Mixed Resultsѻýҕl> FTD/TPI effective, but mFOLFOX plus biologic didn't improve survival Jan 20, 2019
<ѻýҕl>'Incredibly Impressive' Activity in Biliary Ca with Combo Txѻýҕl> Responses in about 40% of patients with BRAF/MEK inhibitor pairing Jan 20, 2019
<ѻýҕl>Surgery/HIPEC Safer Than Other High-Risk Cancer Proceduresѻýҕl> Lower infection, 30-day mortality rates than with Whipple, esophagectomy Jan 15, 2019
<ѻýҕl>Active Smokers Far More Likely to Fail on Chemo for Bladder Caѻýҕl> Higher rates of disease recurrence seen as well Jan 10, 2019
<ѻýҕl>Less Invasive Surgery Wins in Esophageal Cancerѻýҕl> Large reduction in major complications at 1 month out Jan 09, 2019
<ѻýҕl>Trump Proposes Overhaul of Part B Drugsѻýҕl> Plan hinges on benchmarking U.S. prices to those abroad Jan 04, 2019
<ѻýҕl>Cancer Treatment and Arthritis: A Growing Complaintѻýҕl> Will checkpoint inhibitor-related arthritis outstrip RA in frequency? Dec 27, 2018
<ѻýҕl>Increased Risk of Chemo-Associated AML for Nearly All Solid Cancersѻýҕl> Extended beyond 5 years for most types with greater risk seen in young patients Dec 20, 2018
<ѻýҕl>Sorafenib 'New Standard of Care' for Patients With Desmoid Tumorsѻýҕl> Toxicity led to treatment discontinuation in 20% of patients Dec 19, 2018
<ѻýҕl>Visual Guide to AVERT's VTE Prevention in Cancerѻýҕl> Apixaban effective against important chemotherapy side effect Dec 07, 2018
<ѻýҕl>In Lupus, Risks for Cancers Riseѻýҕl> Overall risks increased for both women and men Dec 07, 2018
<ѻýҕl>Cancer-VTE Trial Falls Shortѻýҕl> High dropout rate undermines rivaroxaban prophylaxis trial Dec 05, 2018
<ѻýҕl>Morning Break: Measles Rebound; New FDA Warnings; Cancer Dx Scaresѻýҕl> Health news and commentary from around the Web gathered by the ѻýҕl staff Nov 30, 2018
<ѻýҕl>LMWH Prevails for VTE Prevention in Guidelineѻýҕl> ASH unveils first six chapters of comprehensive recommendations Nov 29, 2018
<ѻýҕl>Highlights from Molecular Targets Symposiuimѻýҕl> Breast cancer gene expression, activity in GI, lung, and limited-mutation tumors Nov 16, 2018
<ѻýҕl>'My Cancer Free Life'? Not So Fastѻýҕl> Reality docuseries as a commercial for quack doc Nov 15, 2018
<ѻýҕl>Regular Aspirin Use Tied to Reduction in HCC Riskѻýҕl> Significant benefit apparent after ≥5 years of use at average dose of at least 1.5 tablets/week Nov 13, 2018
<ѻýҕl>AHA: Fish Oil, Vitamin D Not VITAL to Heart Healthѻýҕl> VITAL trial also showed no benefits for cancer incidence with both supplements Nov 10, 2018 video
<ѻýҕl>NCRI: Highlights from the Annual Conferenceѻýҕl> Prostate cancer tradeoffs, rising melanoma mortality, safer regimen for thyroid cancer Nov 05, 2018
<ѻýҕl>Morning Break: Dead-Butt Syndrome; Last Word on Cellphone Radiation; States vs Pharmaѻýҕl> Health news and commentary from around the Web gathered by the ѻýҕl staff Nov 02, 2018
<ѻýҕl>Pouch Creation a Winner After Total Gastrectomyѻýҕl> Meta-analysis reports better long-term functional outcomes, no greater perioperative morbidity Oct 30, 2018
<ѻýҕl>Hippocampus-Sparing Radiation a New Option in Brain Mets Patientsѻýҕl> Approach preserved cognitive function, but patient prognosis a key consideration Oct 24, 2018
<ѻýҕl>First-Line Anti-PD-1 Ups Survival for Advanced Head/Neck Cancerѻýҕl> Pembrolizumab, with or without chemo, tops current standard Oct 24, 2018
<ѻýҕl>Cetuximab Fails Twice vs Cisplatin for HPV-Related Oral Caѻýҕl> Cetuximab resulted in more patient deaths across U.S., German studies Oct 23, 2018
<ѻýҕl>Liquid Biopsy Rules Out Relapse in HPV-Positive Oral Caѻýҕl> Test had 100% negative predictive value Oct 23, 2018
<ѻýҕl>No 'Sound Science' Behind Avoiding Topical Agents Before RTѻýҕl> Increased dose to skin only seen when applying 'copious' amounts Oct 18, 2018
<ѻýҕl>SBRT Doubles 5-Year Survival in Oligometastatic Cancersѻýҕl> Most patients in phase II trial had up to three metastatic lesions Oct 17, 2018
<ѻýҕl>Alternative Therapies Popular With Sarcoma Patientsѻýҕl> Drug-drug interactions still poorly understood Oct 11, 2018
<ѻýҕl>Inherited JAK3 Mutation May Up Head/Neck Ca Risk in African Americansѻýҕl> About 8% carry the single nucleotide polymorphism Oct 11, 2018
<ѻýҕl>Knowledge Gaps on HPV's Link to Head/Neck Ca for Docs in Trainingѻýҕl> Few are equipped to perform HPV vaccine counseling, study found Oct 10, 2018
<ѻýҕl>SSA Transition Safe, Effective for NETsѻýҕl> Long-term survival, cost-effectiveness examined in other studies Oct 09, 2018
<ѻýҕl>Molecular Profiling Can ID Cancer Risk in Thyroid Lesionsѻýҕl> In lesions with atypia, different mutations confer higher and lower risks Oct 09, 2018
<ѻýҕl>Surgery Improves Survival for most pNETsѻýҕl> Mortality odds 70%-80% lower for all but stage I disease Oct 06, 2018